ARMATA PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Adjustments to Additional Paid in Capital, Warrant Issued of $204.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2018-03-14
- ARMATA PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2016-12-31 was $0.00.
- ARMATA PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2016-09-30 was $0.00.
- ARMATA PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2016-06-30 was $0.00.
- ARMATA PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2016-03-31 was $204.00K.
- ARMATA PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $204.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 0 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $0.00 derived: sum of 3 quarters · filed 2018-03-14 | $204.00K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $204.00K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $204.00K 10-Q · filed 2016-08-15 | |||
| 2016-03-31 | $204.00K 10-Q · filed 2016-05-12 | ||||
| 2015-03-31 | -$4.00M 10-Q · filed 2015-08-13 | ||||
| 2015-03-16 | $4.00M 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |